ABOS
AcumenFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ABOS vs peer average
34/100
ABOS vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 1 · F 6
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
BIIB is the first available peer comparator.
Leqembi provides an Alzheimer's antibody efficacy and ARIA reference, not a small-cap valuation multiple; its commercial maturity differs substantially from Acumen's Phase 2 program.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABOS
Acumen
BIIB
Biogen
Grade
F
C
Momentum
72
92
Value
41
64
Sentiment
25
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs BIIB
ABOS / BIIB
Grade Position
Below peers
ABOS vs. peer average (F vs. D)
34/100
Momentum
72
BIIBValue
41
BIIBSentiment
25
BIIBRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABOS
BIIB is the first peer returned for this comparison set.